Sea Mild Biotechnology Co., Ltd. (TPEX:7516)

Sea Mild Biotechnology Revenue

Sea Mild Biotechnology had revenue of 196.02M TWD in the half year ending June 30, 2026, with 44.16% growth. This brings the company's revenue in the last twelve months to 372.36M, up 6.86% year-over-year. In the year 2025, Sea Mild Biotechnology had annual revenue of 341.94M with 7.25% growth.

• Revenue (ttm): 372.36M
• Revenue Growth: +6.86%
• P/S Ratio: 0.43
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 158.33M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	341.94M	23.11M	7.25%
Dec 31, 2024	318.82M	61.81M	24.05%
Dec 31, 2023	257.02M	54.37M	26.83%
Dec 31, 2022	202.65M	38.83M	23.71%
Dec 31, 2021	163.82M	-44.06M	-21.20%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 1, 2026

Data Sources Report a data error